Geron Corp reports results for the quarter ended March 31 - Earnings Summary
07/05/2025 14:32
Geron Corp GERN.OQ reported a quarterly adjusted loss of 3 cents per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -9 cents. The mean expectation of nine analysts for the quarter was for a loss of 4 cents per share. Wall Street expected results to range from -5 cents to -3 cents per share. Revenue rose 12,927.3% to $39.60 million from a year ago; analysts expected $48.22 million. Geron Corp's reported EPS for the quarter was a loss of 3 cents. The company reported a quarterly loss of $19.84 million. Geron Corp shares had fallen by 17.0% this quarter and lost 62.7% so far this year. FORECAST CHANGES The mean earnings estimate of analysts had risen by about 5.7% in the last three months. In the last 30 days, two analysts negatively revised earnings estimates RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" Wall Street's median 12-month price target for Geron Corp is $4.00 This summary was machine generated from LSEG data May 7 at 01:32 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Mar. 31 2025 | -0.04 | -0.03 | Beat |
| Dec. 31 2024 | -0.05 | -0.04 | Beat |
| Sep. 30 2024 | -0.08 | -0.04 | Beat |
| Jun. 30 2024 | -0.10 | -0.10 | Met |
Recent news on Geron
See all newsBrief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Geron Corporation reports results for the quarter ended June 30 - Earnings Summary
Geron's Q2 revenue rises on RYTELO growth
Brief: Geron Q2 EPS USD -0.02
Brief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)